The effect of high gravidity on the carcinogenesis of mammary gland in TA2 mice

American Journal of Reproductive Immunology

Volumn 63, Issue 5, 2010, Pages 396-409

  Wang, Xuan ^a   Huang, Chun ^a   Sun, Baocun ^a   Gu, Yanjun ^a   Cui, Yanfen ^a   Zhao, Xiulan ^a   Li, Yan ^a   Zhang, Shiwu ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Estradiol; Progesterone; Spontaneous breast cancer; T lymphocyte subsets; TA2 mice

Indexed keywords

ESTRADIOL; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; LYMPHOCYTE COUNT; MOUSE; MULTIPARA; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; PUERPERIUM;

ANIMALS; BREAST NEOPLASMS; FEMALE; GRAVIDITY; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; MICE; PREGNANCY; T-LYMPHOCYTES;

EID: 77953050814     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00807.x     Document Type: Article

References (54)

1. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004, 6:229-239.
2. Kurian AW, Clarke CA, Carlson RW. The decline in breast cancer incidence: real or imaginary? Curr Oncol Rep 2009, 11:21-28.
3. Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S. Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 1999, 96:2520-2525.
4. Russo J, Russo IH. Differentiation and breast cancer. Medicina (B Aires) 1997, 57:s81-s91.
5. Britt K, Ashworth A, Smalley M. Pregnancy and the risk of breast cancer. Endocr Relat Cancer 2007, 14:907-933.
6. Ginestier C, Wicha MS. Mammary stem cell number as a determinate of breast cancer risk. Breast Cancer Res 2007, 9:109-120.
7. Cunningham FG, Williams JW. Williams' Obstetrics 1997, 20th ed, Stamford, Appleton and Lange
8. Siegelmann-Danieli N, Tamir A, Zohar H, Papa MZ, Chetver LL, Gallimidi Z, Stein ME, Kuten A. Breast cancer in women with recent exposure to fertility medications is associated with poor prognostic features. Ann Surg Oncol 2003, 10:1031-1038.
9. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006, 354:270-282.
10. Shen T, Vortmeyer AO, Zhuang Z, Tavassoli FA. High frequency of allelic loss of BRCA2 gene in pregnancy-associated breast carcinoma. J Natl Cancer Inst 1999, 91:1686-1687.
11. Keinan-Boker L, Lerner-Geva L, Kaufman B, Meirow D. Pregnancy-Associated Breast Cancer. Isr Med Assoc J 2008, 10:722-727.
12. Huang H. Spontaenous breast cancer of TA2. Tianjin Med J 1982, 6:345.
13. Lin B, Li Y, Li H, Zhang Y, Liu J. The inbred TA2 mice and their biological traits. Shanghai Xu Mo Shou Yi Tong Xun 1982, 2:1-5.
14. Gao P, Su Y, Gao Y, Liu X, Wang J, Zhang Y. A murine model of mammary endocarcinoma with high rate of spontaneous metastases in the lungs. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1994, 16:147-152.
15. Zhu Y, Zhang SW, Jia XH, Liu FY, Li Y, Wang X, Sun BC. Pathologic characteristic of spontaneous breast cancer in TA mice. Tianjin Yi Ke Da Xue Xue Bao 2007, 13:149-150.
16. Cui YF, Xu SY, Gu YJ, Zhang DF, Zhang SW, Sun BC. Effects of FGF-1 and FGFR1 on the genesis of spontaneous breast cancer in TA2 mice. Chinese Journal of Clinical Oncology 2009, 36:168-171.
17. Li Y, Zhang SW, Jia XH, Gu YJ, Rong Z, Sun BC. Spontaneous breast cancer in F1 hybrids of TA and TA mice and the underlying mechanisms. Zhong Guo Zhong Liu Lin Chuang 2008, 35:405-407.
18. Hall MA, Ahmadi KR, Norman P, Snieder H, MacGregor AJ, Vaughan RW, Spector TD, Lanchbury JS. Genetic influence on peripheral blood T lymphocyte levels. Genes Immun 2000, 1:423-427.
19. Scola L, Giacalone A, Marasà L, Mirabile M, Vaccarino L, Forte GI, Giannitrapani L, Caruso C, Montalto G, Lio D. Genetic determined downregulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer. Ann NY Acad Sci 2009, 1155:284-288.
20. Mukherji B, Chakraborty NG, Sivanandham M. T-cell clones that react against autologous human tumors. Immunol Rev 1990, 116:33-62.
21. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
22. Girón-González JA, Moral FJ, Elvira J, García-Gil D, Guerrero F, Gavilán I, Escobar L. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 2000, 143:31-36.
23. Conticello C, Pedini F, Zeuner A, Patti M, Zerilli M, Stassi G, Messina A, Peschle C, De Maria R. IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins. J Immunol 2004, 172:5467-5477.
24. McKallip RJ, Nagarkatti M, Nagarkatti PS. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J Immunol 2005, 174:3281-3289.
25. Kruse N, Greif M, Moriabadi NF, Marx L, Toyka KV, Rieckmann P. Variations in cytokine mRNA expression during normal human pregnancy. Clin Exp Immunol 2000, 119:317-322.
26. Bocchinfuso WP, Lindzey JK, Hewitt SC, Clark JA, Myers PH, Cooper R, Korach KS. Induction of mammary gland development in estrogen receptor-a knockout mice. Endocrinology 2000, 141:2982-2994.
27. Peck JD, Hulka BS, Poole C, Savitz DA, Baird D, Richardson BE. Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev 2002, 11:361-368.
28. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 1982, 2:5-73.
29. Goodman HM. Basic Medical Endocrinology 1988, New York, Raven Press
30. Miller WR. Hormonal factors and risk of breast cancer. Lancet 1993, 341:25-26.
31. Wang YP. Medical Laboratory Animal Science. Jilin, Jilin Da Xue Chu Ban She. 2005
32. Todorovic R, Devanesan P, Higginbotham S, Zhao J, Gross ML, Rogan EG, Cavalieri EL. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol. Carcinogenesis 2001, 22:905-911.
33. Nilsson S, Gustafsson JA. Estrogen receptor transcription and transactivation: basic aspects of estrogen action. Breast Cancer Res 2000, 2:360-366.
34. Proietti C, Salatino M, Rosemblit C, Carnevale R, Pecci A, Kornblihtt AR, Molinolo AA, Frahm I, Charreau EH, Schillaci R, Elizalde PV. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol Cell Biol 2005, 25:4826-4840.
35. Rajkumar L, Canada A, Esparza D, Collins K, Moreno E, Duong H. Decreasing hormonal promotion is key to breast cancer prevention. Endocrine 2009, 35:220-226.
36. Blank EW, Wong PY, Lakshmanaswamy R, Guzman R, Nandi S. Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats. Proc Natl Acad Sci USA 2008, 105:3527-3532.
37. Watanabe M, Iwatani Y, Kaneda T, Hidaka Y, Mitsuda N, Morimoto Y, Amino N. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol 1997, 37:368-377.
38. Fanti P, Nazareth M, Bucelli R, Mineo M, Gibbs K, Kumin M, Grzybek K, Hoeltke J, Raiber L, Poppenberg K, Janis K, Schwach C, Aronica SM. Estrogen decreases chemokine levels in murine mammary tissue: implications for the regulatory role of MIP-1 alpha and MCP-1/JE in mammary tumor formation. Endocrine 2003, 22:161-168.
39. Leposavić G, Obradović S, Kosec D, Pejcić-Karapetrović B, Vidić-Danković B. In vivo modulation of the distribution of thymocyte subsets by female sex steroid hormones. Int Immunopharmacol 2001, 1:1-12.
40. Obradović S, Vidić-Danković B, Pejcić-Karapetrović B, Kosec D, Leposavić G. In vivo modulation of the splenocyte yield and composition by female sex steroid hormones. Pharmazie 2001, 56:235-238.
41. Song XF, Sun X, Wang H. The regulation of T lymphocyte by estrogen and progesterone. Chin J Cell Mol Immuno1 2005, 21:249.
42. Xia X, Zhang SF, Liu RZ, Lu WX, Liu KD. Effects of different concentrations of estradiol on estrogen receptor expression and Th1/Th2 balance of splenocytes of ovariectomized mice. Zhong Hua Lao Nian Yi Xue Za Zhi 2007, 26:379-382.
43. Segerson EC, Li H, Talbott CW. Estradiol-17 beta and progesterone increase ovine uterine suppressor cell activity. J Anim Sci 1997, 75:2778-2787.
44. Thordarson G, Van Horn K, Guzman RC, Nandi S, Talamantes F. Parous rats regain high susceptibility to chemically induced mammary cancer after treatment with various mammotropic hormones. Carcinogenesis 2001, 22:1027-1033.
45. Szekeres-Bartho J, Faust Z, Varga P, Szereday L, Kelemen K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 1996, 35:348-351.
46. Kelemen K, Paldi A, Tinneberg H, Torok A, Szekeres-Bartho J. Early recognition of pregnancy by the maternal immune system. Am J Reprod Immunol 1998, 39:351-355.
47. Salem MI. Estrogen, a double-edged sword: modulation of TH1-and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curt Drug Targets Inflamm Allergy 2004, 3:97-104.
48. Saito S, Tsukaguchi N, Hasegawa T, Michimata T, Tsuda H, Narita N. Distribution of Th1,Th2 and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. Am J Reprod Immunol 1999, 42:240-245.
49. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997, 18:478-482.
50. Wegmann T, Lin H, Guilbert L, Mosmann T. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon. Immunol Today 1993, 14:353-356.
51. Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T. Quantitative analysis of peripheral blood Th0, Thl, Th2 and the Thl:Th2 cell ratio during normal pregnancy and preeclampsia. Clin Exp Immunol 1999, 117:550-555.
52. Kuklina EM, Shirshov SV. Reproductive hormones in the control of Th1/Th2 cytokine balance. Izv Akad Nauk Ser Biol 2005, 3:273-280.
53. Nishimura T, Nakui M, Sato M, Iwakabe K, Kitamura H, Sekimoto M, Ohta A, Koda T, Nishimura S. The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother Pharmacol 2000, 46:S52-S61.
54. Shen HY, Sun ZJ, Yu B. Expressions and significance of Th1/Th2 in breast carcinoma tissues. Journal of the Fourth Military Medical University 2007, 28:1899-1901.